Evidence map›Paper›PMID 39746942›Full record

ArticleNature communications2025

A fiducial-assisted strategy compatible with resolving small MFS transporter structures in multiple conformations using cryo-EM.

Pujun Xie, Yan Li, Gaëlle Lamon, Huihui Kuang, Da-Neng Wang, Nathaniel J Traaseth

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Miniprotein inhibitors of thebioRxiv : the preprint server for biology · 2026
    Article
  8. Review
  9. Screening ofFrontiers in microbiology · 2026
    Article
  10. Article
  11. Energetic and structural control of polyspecificity in a multidrug transporter.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pujun Xie *Department of Chemistry, New York University, New York, NY, USA.ORCID 0000-0001-8456-3801
Yan Li *Department of Cell Biology, New York University School of Medicine, New York, NY, USA.
Gaëlle LamonDepartment of Chemistry, New York University, New York, NY, USA.
Huihui KuangCryo-EM Core Laboratory, New York University School of Medicine, New York, NY, USA.
Da-Neng WangDepartment of Cell Biology, New York University School of Medicine, New York, NY, USA. da-neng.wang@med.nyu.edu.ORCID 0000-0002-6496-4699
Nathaniel J TraasethDepartment of Chemistry, New York University, New York, NY, USA. traaseth@nyu.edu.ORCID 0000-0002-1185-6088

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MARK Reid PHILIPS · 1985 to 2026
$83.1M
Mechanisms of Allostery and Molecular Recognition in the Small Multidrug Resistance FamilyR01AI108889 · NIAID · NEW YORK UNIVERSITY · PI Nathaniel J. Traaseth · 2014 to 2026
$5.4M
Transport Cycle and Inhibition of Human Na+-dicarboxylate Cotransporter NaDC3R01NS108151 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI DANENG WANG · 2018 to 2026
$4.1M
Transport Mechanisms and Inhibition of Efflux Pumps in Pathogenic OrganismsR01AI165782 · NIAID · NEW YORK UNIVERSITY · PI SHOHEI KOIDE, Nathaniel J. Traaseth · 2022 to 2026
$4.0M
Dynamics and mechanism of sodium-dependent carboxylate transportersR01DK135088 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Ruben L Gonzalez, Emad Tajkhorshid · 2023 to 2026
$2.6M
Structural basis of the Ragulator-Rag GTPase complex as a platform for mTOR activation on the lysosomal surfaceR01GM121994 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI WANG, DANENG · 2017 to 2020
$1.5M
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) AI108889Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) AI165782NCI NIH HHS P30 CA016087NIAID NIH HHS R01 AI108889NIAID NIH HHS R01 AI165782NIDDK NIH HHS R01 DK135088NIGMS NIH HHS R01 GM121994NINDS NIH HHS R01 NS108151NSF | BIO | Division of Molecular and Cellular Biosciences (MCB) 1902449U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) DK135088U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) GM121994U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) NS108151
6 · The paper itself

Abstract

Advancements in cryo-EM have stimulated a revolution in structural biology. Yet, for membrane proteins near the cryo-EM size threshold of approximately 40 kDa, including transporters and G-protein coupled receptors, the absence of distinguishable structural features makes image alignment and structure determination a significant challenge. Furthermore, resolving more than one protein conformation within a sample, a major advantage of cryo-EM, represents an even greater degree of difficulty. Here, we describe a strategy for introducing a rigid fiducial marker (BRIL domain) at the C-terminus of membrane transporters from the Major Facilitator Superfamily (MFS) with AlphaFold2. This approach involves fusion of the last transmembrane domain helix of the target protein with the first helix of BRIL through a short poly-alanine linker to promote helicity. Combining this strategy with a BRIL-specific Fab, we elucidated four cryo-EM structures of the 42 kDa Staphylococcus aureus transporter NorA, three of which were derived from a single sample corresponding to inward-open, inward-occluded, and occluded conformations. Hence, this fusion construct facilitated experiments to characterize the conformational landscape of NorA and validated our design to position the BRIL/antibody pair in an orientation that avoids steric clash with the transporter. The latter was enabled through AlphaFold2 predictions, which minimized guesswork and reduced the need for screening several constructs. We further validated the suitability of the method to three additional MFS transporters (GlpT, Bmr, and Blt), results that supported a rigid linker between the transporter and BRIL. The successful application to four MFS proteins, the largest family of secondary transporters in nature, and analysis of predicted structures for the family indicates this strategy will be a valuable tool for studying other MFS members using cryo-EM.

Indexed as

Cryoelectron MicroscopyMembrane Transport ProteinsBacterial ProteinsFiducial MarkersModels, MolecularProtein ConformationProtein DomainsStaphylococcus aureusBacterial ProteinsMembrane Transport Proteins

Identifiers

PMID39746942
PMCPMC11695964

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.